Interstitial lung disease

There are 119 papers on interstitial lung disease in aging research: 3 trials and 79 observational studies in people, 2 in animals, 1 in cells, 30 reviews. The newest story, Oct 30, 2026: “Blood proteins linked to later lung-scarring disease”.

Disease

119 papers study it111 more mention it30 findings

9 new papers in 30 daysSee all 230 papers on interstitial lung disease

“HCQ initiation was associated with significantly higher 10-year relative risks (RR) for NSTEMI (RR: 1.217), ESRD (RR: 2.624), ILD (RR: 1.377), PAH (RR: 1.625), and all-cause mortality (RR: 1.379)”
Comparative risks of mortality, cardiovascular events, and dementia with methotrexate versus hydroxychloroquine in rheumatoid arthritis: a retrospective cohort studyAnnals of medicine and surgery (2012)2025doi:10.1097/ms9.0000000000004182
  • Human trial3
  • Humans79
  • Animals2
  • Cells1
  • In silico1

Effects

7

Mortality

no changein humans1

1 study
  1. Interstitial lung disease was not clearly linked with mortality in humans (Rheumatoid arthritis with bronchiectasis).

    “When limited to bronchiectasis patients with and without ILD, the complication of ILD did not influence the mortality risk.”

    HumansRheumatoid arthritis with bronchiectasisMean follow-up of 9.7 years

    Impact of Bronchiectasis on Long-Term Mortality in Patients with Rheumatoid Arthritis: A Real-World Retrospective Cohort Study

    Journal of clinical medicine

Health-related quality of life

downin humans1

1 study
  1. Interstitial lung disease is linked with worse health-related quality of life in humans (mean EQ-VAS 56.5 ± 23.7).

    “health-related quality of life was reduced (mean EQ-VAS 56.5 ± 23.7)”

    Humansn = 69

    The Patient Journey in Interstitial Lung Disease: Mobility, Independence, and Psychological Burden

    Journal of clinical medicine

Mobility

downin humans1

1 study
  1. Interstitial lung disease is linked with worse mobility in humans (55% mobile for fewer than two hours per day).

    “55% were mobile for fewer than two hours per day, 73% reported mobility impairment”

    Humansn = 69

    The Patient Journey in Interstitial Lung Disease: Mobility, Independence, and Psychological Burden

    Journal of clinical medicine

Telomere length

no changein silico1OR 0.996

1 study
  1. Interstitial lung disease showed no clear effect on telomere length in silico (OR 0.996, 95% CI 0.989-1.004).

    “or telomere length (odds ratio = 0.996, 95% confidence interval: 0.989-1.004, p = 0.328).”

    In silico

    Causality between aging and interstitial lung disease: A bidirectional two-sample Mendelian randomization study

    The Journal of international medical research

More on Telomere length

Facial aging

no changein silico1OR 0.999

1 study
  1. Interstitial lung disease showed no clear effect on facial aging in silico (OR 0.999, 95% CI 0.995-1.003).

    “interstitial lung disease had no significant effect on facial aging (odds ratio = 0.999, 95% confidence interval: 0.995-1.003, p = 0.664)”

    In silico

    Causality between aging and interstitial lung disease: A bidirectional two-sample Mendelian randomization study

    The Journal of international medical research

More on Facial aging

Quality of life

downin humans1

1 study
  1. Interstitial lung disease is linked with worse quality of life in humans (compared with control subjects).

    “higher dyspnoea and depression scores, and worse QoL”

    Humanscompared with control subjects

    Functional clinical impairments and frailty in interstitial lung disease patients

    ERJ open research

Physical function

downin humans1

1 study
  1. Interstitial lung disease is linked with worse physical function in humans (compared with control subjects).

    “Compared with control subjects, ILD participants exhibited significantly lower performance in every exercise and functional capacity test”

    Humanscompared with control subjects

    Functional clinical impairments and frailty in interstitial lung disease patients

    ERJ open research

Associations

18

Telomere length

downin humans2downin silico2OR 0.09–0.632

4 studies
  1. Telomere length is linked with a lower risk of interstitial lung disease in humans (Outlier-robust Mendelian randomisation using 77 instruments in FinnGen R12) (OR 0.59 per SD longer telomeres, 95% CI 0.49–0.71).

    “Longer telomeres reduced ILD risk: outlier-robust IVW odds ratio (OR) 0.59 per standard deviation (SD), 95% CI 0.49-0.71, p = 2.7 x 10^-8”

    HumansOutlier-robust Mendelian randomisation using 77 instruments in FinnGen R12

    Longer telomeres linked to lower lung disease risk

    medRxivPreprint

  2. Telomere length is linked with a lower risk of interstitial lung disease in humans (genetically predicted by nine single-nucleotide polymorphisms) (OR 0.29, 95% CI 0.14-0.61, P = 0.001).

    “and ILD (OR = 0.29; 95 % CI: 0.14, 0.61; P = 0.001)”

    Humansgenetically predicted by nine single-nucleotide polymorphisms

    Genetically determined telomere length and its association with chronic obstructive pulmonary disease and interstitial lung disease in biobank Japan: A Mendelian randomization study

    Heliyon

  3. Telomere length lowers the risk of interstitial lung disease in silico (OR 0.632, 95% CI 0.523-0.765).

    “Telomere length was negatively correlated with interstitial lung disease risk (odds ratio: 0.632, 95% confidence interval: 0.523-0.765, p < 0.001).”

    In silico

    Causality between aging and interstitial lung disease: A bidirectional two-sample Mendelian randomization study

    The Journal of international medical research

  4. Telomere length lowers the risk of interstitial lung disease in silico (OR 0.09 (95% CI 0.05-0.15)).

    “and interstitial lung disease (OR, 0.09 [95% CI, 0.05-0.15]).”

    In silico

    Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study

    JAMA oncology

More on Telomere length

Mortality

upin humans2HR 3.16

2 studies
  1. Interstitial lung disease is associated with mortality in humans (Rheumatoid arthritis; interstitial lung disease without bronchiectasis) (Adjusted HR 3.16, 95% CI 1.92–5.22).

    “The adjusted hazard ratio (95% CI) was 2.37 (1.48–3.82) for bronchiectasis alone and 3.16 (1.92–5.22) for ILD alone.”

    HumansRheumatoid arthritis; interstitial lung disease without bronchiectasisMean follow-up of 9.7 yearsn = 766

    Impact of Bronchiectasis on Long-Term Mortality in Patients with Rheumatoid Arthritis: A Real-World Retrospective Cohort Study

    Journal of clinical medicine

  2. Interstitial lung disease is associated with mortality in humans (COVID-19) (adjOR = 1.35, 95% CI: 1.28-1.42).

    “interstitial lung disease (adjOR = 1.35, CI:1.28-1.42); low or normal body mass index (adjOR:1.03, CI:1.00-1.07); higher comorbidity index (adjOR = 1.01, CI:1.01-1.02)”

    HumansCOVID-19n = 4,783

    Geriatrics-focused indicators predict mortality more than age in older adults hospitalized with COVID-19

    BMC geriatrics

Frailty

upin humans2

2 studies
  1. Interstitial lung disease is associated with frailty in patients with interstitial lung disease assessed by Fried Frailty Phenotype (35% (95% CI 25%-45%)).

    “The pooled prevalence of frailty was 35% (95% CI 25%-45%) by FFP”

    Reviewin patients with interstitial lung disease assessed by Fried Frailty Phenotype

    Prevalence and assessment of frailty in interstitial lung disease - a systematic review and meta-analysis

    Chronic respiratory disease

  2. Interstitial lung disease raises the risk of frailty in people living with ILD.

    “ILD extent may proportionally accelerate age-related vulnerabilities.”

    Reviewin people living with ILD

    Ageing with Interstitial lung disease: preserving health and well being

    Current opinion in pulmonary medicine

Restriction with normal spirometry

upin humans1

1 study
  1. Interstitial lung disease is associated with restriction with normal spirometry in patients with normal spirometry (aOR 3.65, 95% CI 3.43-3.88).

    “patients with a diagnosis (aOR 3.65, 95% CI 3.43-3.88) or radiographic evidence (aOR 3.02, 95% CI 2.79-3.28) of interstitial lung disease (ILD).”

    Humansin patients with normal spirometryn = 47,597

    D102-01 Restriction With Normal Spirometry: A Retrospective Cohort Study

    American Journal of Respiratory and Critical Care Medicine

More on Restriction with normal spirometry

Montreal Cognitive Assessment score below 26

upin humans1

1 study
  1. Interstitial lung disease is associated with montreal Cognitive Assessment score below 26 in humans (ILD versus non-ILD patients) (45% versus 19%).

    “MoCA scores < 26 were more common in those with ILDs (45% vs. 19%; p = 0.01).”

    HumansILD versus non-ILD patientsn = 77

    Neurological Symptom Frequency, Cognitive Dysfunction, and Motor Impairment in Patients with Interstitial Lung Disease: A Cross-Sectional Analysis

    Journal of clinical medicine

Single-leg stance score

downin humans1

1 study
  1. Interstitial lung disease is associated with single-leg stance score in humans (ILD versus non-ILD patients) (7.2 ± 3.1 versus 9.1 ± 3.8 s).

    “ILD patients showed lower mean SLS scores (7.2 ± 3.1 vs. 9.1 ± 3.8 s, p = 0.03)”

    HumansILD versus non-ILD patientsn = 77

    Neurological Symptom Frequency, Cognitive Dysfunction, and Motor Impairment in Patients with Interstitial Lung Disease: A Cross-Sectional Analysis

    Journal of clinical medicine

Neurological involvement

upin humans1OR 3.12

1 study
  1. Interstitial lung disease is associated with neurological involvement in humans (OR 3.12, 95% CI 1.27–7.65).

    “Logistic regression revealed ILD diagnosis (OR = 3.12, 95% CI: 1.27-7.65, p = 0.013)”

    Humansn = 77

    Neurological Symptom Frequency, Cognitive Dysfunction, and Motor Impairment in Patients with Interstitial Lung Disease: A Cross-Sectional Analysis

    Journal of clinical medicine

More on Neurological involvement

Restriction with normal spirometry

upin humans1

1 study
  1. Interstitial lung disease is associated with restriction with normal spirometry in humans (aOR 3.65, 95% CI 3.43-3.88).

    “Restriction with normal spirometry was more likely in older patients (adjusted odds ratio [aOR] 1.01 per year, 95% CI 1.01-1.01), in non-White patients (aOR 1.33, 95% CI 1.26-1.41), and in patients with a diagnosis (aOR 3.65, 95% CI 3.43-3.88) or radiographic evidence (aOR 3.02, 95% CI 2.79-3.28) of interstitial lung disease (ILD).”

    Humans59.8% femalesn = 47,597

    Restriction with Normal Spirometry: A Retrospective Cohort Study

    medRxiv : the preprint server for health sciencesPreprint

Anxiety and depression

upin humans1+78%

1 study
  1. Interstitial lung disease is associated with anxiety and depression in humans (78%).

    “high rates of anxiety/depression (78%)”

    Humansn = 69

    The Patient Journey in Interstitial Lung Disease: Mobility, Independence, and Psychological Burden

    Journal of clinical medicine

More on Anxiety and depression

Hydroxychloroquine

upin humans1RR 1.377

1 study
  1. Hydroxychloroquine is linked with a higher risk of interstitial lung disease in humans (compared with methotrexate initiators after propensity score matching) (RR 1.377).

    “HCQ initiation was associated with significantly higher 10-year relative risks (RR) for NSTEMI (RR: 1.217), ESRD (RR: 2.624), ILD (RR: 1.377), PAH (RR: 1.625), and all-cause mortality (RR: 1.379)”

    Humanscompared with methotrexate initiators after propensity score matching10 yearsn = 56,362

    Comparative risks of mortality, cardiovascular events, and dementia with methotrexate versus hydroxychloroquine in rheumatoid arthritis: a retrospective cohort study

    Annals of medicine and surgery (2012)

More on Hydroxychloroquine

All 18

Trial sponsors

Funding

10 grants since 2020

National Heart, Lung, and Blood Institute$4.4MJapan Society for the Promotion of Science¥12.9MNational Institute on Aging$572K

Contains public sector information licensed under the Open Government Licence v3.0.

Latest

Dec 2025: 7Jan 2026: 12Feb 2026: 7Mar 2026: 19Apr 2026: 4May 2026: 10Jun 2026: 11Jul 2026: 4Aug 2026: 8Sep 2026: 7Oct 2026: 7Nov 2026: 5101 papers in 12 months
Frontiers in Immunology

Blood proteins linked to later lung-scarring disease

Among 52,743 participants initially free of interstitial lung disease, 277 blood proteins were linked to later diagnoses over an average 14.4 years.Among 52,743 participants initially free of interstitial lung disease, 277 blood proteins were linked to later diagnoses over an average 14.4 years.

Cohort · 52,743 peopleBiomarkers
medRxiv

Longer telomeres linked to lower lung disease risk

Longer telomeres were linked to lower odds of interstitial lung disease, with an odds ratio of 0.59 per standard-deviation increase in length.Longer telomeres were linked to lower odds of interstitial lung disease, with an odds ratio of 0.59 per standard-deviation increase in length.

Preprint: Mendelian randomizationTelomerase and telomere maintenance

See all 230 papers on interstitial lung disease